Abatacept (BMS-188667)

BIOLOGICAL2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Rheumatoid Arthritis

Phase 1

Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb

CompletedNCT01439204

Bristol-Myers SquibbRheumatoid Arthritis

Start: 2011-10-31End: 2012-02-29Updated: 2014-03-19

Phase 2

Abatacept With Methotrexate- Phase IIB

CompletedNCT00162266

Bristol-Myers SquibbRheumatoid Arthritis

Start: 2000-10-31End: 2009-09-30Updated: 2012-06-01

Related Papers

Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs.

2014-04-2311 citations